Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis
Asian Journal of Andrology · 2026-11 · 28 (6) · 814-822
DOI: 10.4103/aja202635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Andrology, online erschienen am 18.09.2026. Verfasst von Xiao-Xuan Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Cell Cycle Proteins, Proto-Oncogene Proteins, Spermatogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Onvansertib (ONV) is a selective inhibitor of polo-like kinase 1 (PLK1) and has promise in treating cancer. However, its potential effects on male reproductive function remain insufficiently characterized. In this study, male mice received clinically relevant doses of ONV by intragastric gavage for five consecutive days. Evaluations conducted on day 1, day 6, and day 35 after treatment revealed a marked increase in germ cell apoptosis accompanied by a significant reduction in epididymal sperm counts, whereas somatic cell architecture was preserved. Mechanistically, PLK1 inhibition by ONV led to a pronounced decrease in eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) phosphorylation. This disruption is likely linked to impaired meiotic centrosome maturation and aberrant spindle organization in germ cells. Collectively, these findings demonstrate that ONV preferentially induces apoptosis in germ cells via PLK1 suppression, thereby compromising spermatogenic capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing Medical University, Nanjing 211166, China.
- State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing 211166, China.
- State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
- Jinhua Municipal Central Hospital, Jinhua 321000, China.
- Department of Histology and Embryology, State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing 211166, China.
Zitieren
APA
Qi, X. X., Feng, X., Zhu, W. R., Song, T. Y., Li, H. L., Liu, Q., Xu, C. Y., Yuan, Y., Cheng, Q., & Li, L. H. (2026). Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis. Asian Journal of Andrology, 28(6), 814-822. https://doi.org/10.4103/aja202635
Vancouver
Qi XX, Feng X, Zhu WR, Song TY, Li HL, Liu Q, et al. Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis. Asian Journal of Andrology. 2026;28(6):814-822. doi:10.4103/aja202635
BibTeX
@article{Qi2026,
author = {Qi, Xiao-Xuan and Feng, Xin and Zhu, Wen-Rui and Song, Tian-Yi and Li, Hui-Ling and Liu, Qiang and Xu, Chao-Yang and Yuan, Yan and Cheng, Qing and Li, Lai-Hua},
title = {Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis},
journal = {Asian Journal of Andrology},
year = {2026},
volume = {28},
number = {6},
pages = {814--822},
doi = {10.4103/aja202635}
}
EUVIMED